Related Experiment Video
Updated: Dec 28, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Managing the elderly patient with hypertension: current strategies, challenges, and considerations
1Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Vaslhalla, NY, USA.
Insights
Hypertension management in older adults involves lifestyle changes and medication, guided by recent ACC/AHA and ESC/ESH guidelines. Individualized treatment is crucial for elderly patients with comorbidities.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypertension is a primary modifiable risk factor for global cardiovascular events and mortality.
- Managing hypertension in the elderly is critical due to age-related physiological changes and increased cardiovascular risk.
Purpose of the Study:
- To review current clinical trials and guidelines for treating hypertension in the elderly.
- To discuss the application of the 2017 ACC/AHA and 2018 ESC/ESH hypertension guidelines in older populations.
- To address the treatment of resistant hypertension in elderly individuals.
Main Methods:
- Extensive literature review of PubMed articles and clinical trials from 1976 to January 2020.
- Focus on studies concerning hypertension treatment in the elderly population.
- Analysis of major hypertension guidelines relevant to elderly care.
Main Results:
- The 2017 ACC/AHA guidelines recommend treating elderly individuals (≥65 years) with SBP ≥130 mmHg using lifestyle and medication to achieve <130/80 mmHg.
- Treatment decisions for elderly patients with comorbidities require clinical judgment, patient preference, and a team-based risk/benefit assessment.
Conclusions:
- Current guidelines provide a framework for hypertension management in the elderly.
- Individualized treatment strategies are essential, especially for elderly patients with multiple health issues.
- Further research may refine treatment protocols for specific elderly subgroups.
Abstract:
Introduction: Hypertension is the leading modifiable risk factor for cardiovascular events and mortality in the world.Areas covered: An extensive literature review of articles and clinical trials on PUBMED on the topic of hypertension in the elderly from 1976 through January 2020 was conducted. This review article discusses clinical trials on treatment of hypertension in the elderly, the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines, the 2018 European Society of Cardiology/European Society of Hypertension guidelines, and the treatment of hypertension and of resistant hypertension in the elderly.Expert opinion: The 2017 ACC/AHA hypertension guidelines recommend treatment of noninstitutionalized ambulatory community-dwelling adults aged 65 years and older with an average systolic blood pressure of 130 mm Hg or higher with lifestyle measures plus antihypertensive drug to lower the blood pressure to less than 130/80 mm Hg. For elderly adults with hypertension and a high burden of comorbidities and limited life expectancy, clinical judgment, patient preference, and a team-based approach to assess risk/benefit is reasonable for decisions about the intensity of SBP lowering and the choice of antihypertensive drugs to use for treatment.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Drug Dosing: Geriatric Patients
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis IV: Nursing Management
Hypertension I: Introduction